BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 15631107)

  • 1. [Miss-management in treatment failure of pulmonary tuberculosis].
    Ito K; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2004 Oct; 79(10):561-7. PubMed ID: 15631107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A controlled clinical trial of long course chemotherapy regimens containing rifabutin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Zhu LZ; Fu Y; Chu NH; Ye ZZ; Xiao HP; Wang W; Yuan SL; Zhang X; Luo YA; Ma LP
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):520-3. PubMed ID: 17074263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].
    Yoshiyama T; Ito K; Ogata H; Aono A; Wada M
    Kekkaku; 2005 Jan; 80(1):9-14. PubMed ID: 15839057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of clinical status of pulmonary tuberculosis in Southern Taiwan.
    Tsai MS; Chong IW; Hwang JJ; Wang TH; Huang MS
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):136-9. PubMed ID: 15272756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].
    Ogawara M; Sakatani M
    Kekkaku; 1998 Nov; 73(11):673-7. PubMed ID: 9866930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
    Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reasons for chronic expectoration--case reports].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):244-8. PubMed ID: 9489422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Chen QL; Chen L; Yin JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
    Takashima T; Danno K; Tamura Y; Nagai T; Matsumoto T; Han Y; Ano H; Yoshida H; Kawahara K; Tsuyuguchi I
    Kekkaku; 2006 Jun; 81(6):413-8. PubMed ID: 16838679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
    Mitnick C; Bayona J; Palacios E; Shin S; Furin J; Alcántara F; Sánchez E; Sarria M; Becerra M; Fawzi MC; Kapiga S; Neuberg D; Maguire JH; Kim JY; Farmer P
    N Engl J Med; 2003 Jan; 348(2):119-28. PubMed ID: 12519922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.